
In U.S.-EU trade dispute, Trump claims Europe doesn't buy American cars or food. Is that true?
The EU negotiates trade policy as a single entity and was the U.S.'s top goods trading partner in 2024, according to U.S. Census Bureau data. In 2024, the U.S. imported around $606 billion in goods from the EU and exported around $370 billion worth of products to it.
EU leaders have warned they're prepared to impose higher tariffs on hundreds of U.S. imports unless a deal can be reached in the coming weeks. Economists say the dispute could drive up consumer prices on both sides of the Atlantic.
Mr. Trump has defended tariffs as necessary to protect American workers, pointing to the trade imbalance on goods and higher EU tariffs as evidence the bloc has treated the U.S unfairly for years.
The president has also repeatedly said the European Union does not buy American cars or agricultural products. However, trade data from 2024 shows that's inaccurate. While the U.S. has imported more cars and agricultural products from Europe in recent years than it exports there, the EU remains a significant market for these American products.
Here's a breakdown of the data.
President Trump has repeatedly suggested Europe does not buy agricultural goods from U.S. farmers and producers.
"The European Union is, in many ways, nastier than China, OK?," President Trump said at an event May 12. "They sell us their agricultural products. We sell them virtually none. They don't take our products."
But according to the U.S. Department of Agriculture, the EU was the fourth-largest buyer of American agricultural products in 2024, purchasing a record $12.8 billion in these goods. Top exports to the EU included oilseeds like sunflower and sesame seeds, nuts and processed nut products like peanut butter, and soybeans.
By comparison, the U.S. imported $36 billion in agricultural products from the EU in 2024 — buying billions of dollars worth of European wine, animal products, and grains and feeds.
The White House has not responded to a request for clarification on the president's claim.
Before Mr. Trump raised tariffs to a baseline of 10% in April, the EU maintained a higher average tariff on foreign agricultural products than the United States. In 2023, the EU average tariff on foreign agricultural goods was 10.8%, compared to the U.S. rate of 5%.
Certain American food products are also less available in Europe because of consumer preferences and regulations, as the EU bans some American food products that contain certain additives they have deemed unsafe for human consumption.
Another frequent target of President Trump's criticism is the EU's trade imbalance on cars.
"They sell us 13 million cars. We sell them none," Mr. Trump claimed at an event in May.
It is true that the United States imports far more European vehicles than the number of American-made vehicles it exports to the EU, but the EU does buy some American cars.
In 2024, the EU imported about 165,000 American vehicles, valued at roughly $8.8 billion at current exchange rates, according to a report by the European Automobile Manufacturers' Association. By comparison, the same data shows the U.S. imported about 750,000 vehicles from the EU in 2024, worth $43 billion.
Both trading partners have long imposed tariffs on foreign vehicles. The EU charges a 10% tariff on U.S. passenger cars, while the U.S. charged 2.5% on EU passenger cars until Mr. Trump raised the tariff on all foreign vehicles to 25%. The U.S. has also maintained a 25% tariff on EU pickup trucks since the 1960s.
Apart from tariffs, industry analysts say U.S. cars are less competitive in the EU market for a number of other reasons, including that the member nations tend to have higher fuel economy standards, higher gas costs, and their buyers tend to prefer smaller cars.
Though Mr. Trump often focuses on cars, they're not the biggest sector. Biological products and medication are actually the top commodities the U.S. imports from the EU, according to data from the U.S. Census Bureau. This is driven partly by some American pharmaceutical companies maintaining manufacturing facilities in EU countries with lower corporate tax rates like Ireland.
In recent weeks, President Trump has floated tariff rates as high as 200% on foreign-made pharmaceuticals unless companies onshore manufacturing to the U.S.
On the export side, the top U.S. exports to the EU include oil and natural gas, airplanes, and immunological products like blood plasma.
Over the weekend, European Commission chief Ursula von der Leyen said the EU still hopes to reach a new agreement with the U.S.
"We have always been clear that we prefer a negotiated solution," von der Leyen said, adding, "We will continue to prepare countermeasures so we are fully prepared."Rachel Gold
contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
SAP shares seen lower after second-quarter results
BERLIN (Reuters) -Shares in German software maker SAP were seen opening 1.6% lower on Wednesday after the company reported a second quarter boosted by strong cloud demand and cost cuts but held off on increasing full-year targets. SAP reported an 83% year-on-year jump in its free cash flow, used to measure dividends to investors, to 2.36 billion euros ($2.77 billion), exceeding market expectations by about a billion. "As we move into the second half, we remain cautiously optimistic, keeping a close eye on geopolitical developments and public sector trends," finance chief Dominik Asam said upon releasing the quarterly results late on Tuesday. SAP maintained its annual guidance, despite hopes from some investors for an upward revision of its profit target. ($1 = 0.8523 euros) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Clorox Earnings Preview: What to Expect
Oakland, California-based The Clorox Company (CLX) manufactures and markets consumer and professional products. It operates through Health and Wellness, Household, Lifestyle, and International segments. With a market cap of $15.6 billion, Clorox's portfolio consists of diverse brands sold in more than 100 countries and nearly every region of the world. The company is expected to release its Q4 results after the market closes on Thursday, Jul. 31. Ahead of the event, analysts expect CLX to report an EPS of $2.24, up an impressive 23.1% from $1.82 reported in the year-ago quarter. While the company has missed Street's bottom-line estimates once over the past four quarters, it has surpassed the projections on three other occasions. More News from Barchart Opendoor Stock Is Surging Higher in a Frenzied Retail Rally. How Should You Play OPEN Shares Here? Nvidia Stock Warning: This NVDA Challenger Just Scored a Major Customer Analysts Are Cutting Their Price Targets for UnitedHealth Stock Before Q2 Earnings. Is It Time to Ditch Shares? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full fiscal 2025, its EPS is expected to come in at $7.08, marking a solid 14.8% growth from $6.17 in fiscal 2024. But in fiscal 2026, its earnings are expected to plunge 8.6% year-over-year to $6.47 per share. CLX stock prices have dipped 2.4% over the past 52 weeks, notably underperforming the S&P 500 Index's ($SPX) 13.4% returns and the Consumer Staples Select Sector SPDR Fund's (XLP) 4.5% uptick during the same time frame. CLX stock prices dropped 2.4% in the trading session after the release of its disappointing Q3 results on May 5. Due to an unfavorable price mix, the company's organic sales dropped by 2% year-over-year. Further, its overall sales dropped 8.1% year-over-year to $1.7 billion due to divestitures of the VMS and Argentina businesses. This figure missed consensus estimates by a large margin. Moreover, its adjusted EPS plunged 15.2% year-over-year to $1.45, missing the consensus estimates by 7.6%, breaking its 10 quarters long streak of positive earnings surprises. CLX stock maintains a consensus 'Hold' rating overall, as analysts remain cautious about its prospects. Of the 18 analysts covering the stock, opinions include only one 'Strong Buy,' 13 'Holds,' and four 'Strong Sell' ratings. As of writing, the stock is trading slightly below its mean price target of $134.69. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Trump says Japan, US to form LNG joint venture
By Yuka Obayashi and Katya Golubkova TOKYO (Reuters) -U.S. President Donald Trump said on Tuesday that Japan will form a joint venture to develop a liquefied natural gas project in Alaska though a Japanese government official said he was not aware of such plans. It was not immediately clear whether Trump was referring specifically to the proposed $44 billion Alaska LNG project. That project would consist of an 800-mile (1,300-km) pipeline carrying gas to a planned liquefaction plant for export. Trump's announcement of the venture came in comments to lawmakers at the White House where he discussed his trade deal with Japan. "We concluded the one deal ... and now we're going to conclude another one because they're forming a joint venture with us at, in Alaska, as you know, for the LNG," Trump told the lawmakers. "They're all set to make that deal now." The METI official, who oversees resource development, said the agency is working to confirm Trump's comments. Several companies from Japan have expressed an interest in buying LNG from the project, along with Thailand's PTT and India's GAIL. JERA and Tokyo Gas, Japan's two biggest LNG buyers, have expressed their interest in the Alaska LNG project but said they would need to assess specific conditions, including costs, before moving forward. But when asked about the joint venture mentioned by Trump, a JERA spokesperson said they could not confirm it. A Tokyo Gas spokesperson declined to comment, saying the company is not involved in a joint venture for LNG in Alaska and is not familiar with the details. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data